Risk Factors for Falls and Neurocognitive Disorders CLSA

计划入组 12,000 人 · 首次发布于 2018 年 8 月 14 日

The "Motoric Cognitive Risk" Syndrome in the Canadian Population

计划入组 1,461 人 · 首次发布于 2018 年 9 月 20 日

FostrSpace-CASA R61/R33

计划入组 400 人 · 首次发布于 2025 年 3 月 13 日

CUSA-081

CLSP-1025

CSA-144 (CSA BioTech)

Casa Minerals Inc

United States

Cesa Projects International

CLS PHARMA

France

Morgan Stanley Upgrades Charles River Laboratories to Overweight, Citing Biopharma Funding Rebound and AI-Driven Discovery Tailwinds

Acrivon Therapeutics Launches CLIA-Certified Laboratory to Advance Precision Medicine Development

Nanostics Secures CPSA Accreditation for Relocated Prostate Cancer Diagnostic Lab in Edmonton